APA (7th ed.) Citation

JS, L., MC, B., MA, O., A, S., A, G., MH, W., . . . Sawczuk, I. S. (2003). Bacillus Calmete-Guérin plus interferon-alpha2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity. Urologic Oncology, 21(5), 354. https://doi.org/10.1016/s1078-1439(03)00012-7

Chicago Style (17th ed.) Citation

JS, Lam, et al. "Bacillus Calmete-Guérin Plus Interferon-alpha2B Intravesical Therapy Maintains an Extended Treatment Plan for Superficial Bladder Cancer with Minimal Toxicity." Urologic Oncology 21, no. 5 (2003): 354. https://doi.org/10.1016/s1078-1439(03)00012-7.

MLA (9th ed.) Citation

JS, Lam, et al. "Bacillus Calmete-Guérin Plus Interferon-alpha2B Intravesical Therapy Maintains an Extended Treatment Plan for Superficial Bladder Cancer with Minimal Toxicity." Urologic Oncology, vol. 21, no. 5, 2003, p. 354, https://doi.org/10.1016/s1078-1439(03)00012-7.